Gohagan JK - Search Results

1

Prostate cancer screening: what we know and what we need to know.

Kramer BS, Brown ML, Prorok PC, Potosky AL, Gohagan JK. Kramer BS, et al. Among authors: gohagan jk. Ann Intern Med. 1993 Nov 1;119(9):914-23. doi: 10.7326/0003-4819-119-9-199311010-00009. Ann Intern Med. 1993. PMID: 7692780

2

Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial.

Pinsky PF, Andriole GL, Kramer BS, Hayes RB, Prorok PC, Gohagan JK; Prostate, Lung, Colorectal and Ovarian Project Team. Pinsky PF, et al. Among authors: gohagan jk. J Urol. 2005 Mar;173(3):746-50; discussion 750-1. doi: 10.1097/01.ju.0000152697.25708.71. J Urol. 2005. PMID: 15711261

3

Cumulative incidence of false-positive results in repeated, multimodal cancer screening.

Croswell JM, Kramer BS, Kreimer AR, Prorok PC, Xu JL, Baker SG, Fagerstrom R, Riley TL, Clapp JD, Berg CD, Gohagan JK, Andriole GL, Chia D, Church TR, Crawford ED, Fouad MN, Gelmann EP, Lamerato L, Reding DJ, Schoen RE. Croswell JM, et al. Among authors: gohagan jk. Ann Fam Med. 2009 May-Jun;7(3):212-22. doi: 10.1370/afm.942. Ann Fam Med. 2009. PMID: 19433838 Free PMC article. Clinical Trial.

4

The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource.

Zhu CS, Pinsky PF, Kramer BS, Prorok PC, Purdue MP, Berg CD, Gohagan JK. Zhu CS, et al. Among authors: gohagan jk. J Natl Cancer Inst. 2013 Nov 20;105(22):1684-93. doi: 10.1093/jnci/djt281. Epub 2013 Oct 10. J Natl Cancer Inst. 2013. PMID: 24115361 Free PMC article. Review.

5

Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years.

Pinsky PF, Prorok PC, Yu K, Kramer BS, Black A, Gohagan JK, Crawford ED, Grubb RL, Andriole GL. Pinsky PF, et al. Among authors: gohagan jk. Cancer. 2017 Feb 15;123(4):592-599. doi: 10.1002/cncr.30474. Epub 2016 Dec 1. Cancer. 2017. PMID: 27911486 Free PMC article. Clinical Trial.

6

NIH Consensus 1994: screening.

Kramer BS, Gohagan J, Prorok PC. Kramer BS, et al. Gynecol Oncol. 1994 Dec;55(3 Pt 2):S20-1. doi: 10.1006/gyno.1994.1335. Gynecol Oncol. 1994. PMID: 7835804 Review.

7

A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers.

Kramer BS, Gohagan J, Prorok PC, Smart C. Kramer BS, et al. Cancer. 1993 Jan 15;71(2 Suppl):589-93. doi: 10.1002/cncr.2820710215. Cancer. 1993. PMID: 8420681 Clinical Trial.

8

Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute.

Gohagan JK, Prorok PC, Kramer BS, Cornett JE. Gohagan JK, et al. J Urol. 1994 Nov;152(5 Pt 2):1905-9. doi: 10.1016/s0022-5347(17)32412-6. J Urol. 1994. PMID: 7523735 Clinical Trial.

9

Prostate cancer screening: current issues.

Prorok PC, Potosky AL, Gohagan JK, Kramer BS. Prorok PC, et al. Among authors: gohagan jk. Cancer Treat Res. 1996;86:93-112. doi: 10.1007/978-1-4613-1265-9_7. Cancer Treat Res. 1996. PMID: 8886440 Review. No abstract available.

10

Is screening for prostate cancer the current gold standard?--"no".

Kramer BS, Gohagan JK, Prorok PC. Kramer BS, et al. Among authors: gohagan jk. Eur J Cancer. 1997 Mar;33(3):348-53. Eur J Cancer. 1997. PMID: 9155515 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page